These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 18844328)

  • 21. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women.
    Ishiwata N; Melby MK; Mizuno S; Watanabe S
    Menopause; 2009; 16(1):141-8. PubMed ID: 19131846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial.
    Kawai M; Hirano T; Arimitsu J; Higa S; Kuwahara Y; Hagihara K; Shima Y; Narazaki M; Ogata A; Koyanagi M; Kai T; Shimizu R; Moriwaki M; Suzuki Y; Ogino S; Kawase I; Tanaka T
    Int Arch Allergy Immunol; 2009; 149(4):359-68. PubMed ID: 19295240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial.
    Bäurle P; Suter A; Wormstall H
    Forsch Komplementmed; 2009 Jun; 16(3):156-61. PubMed ID: 19657199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cognitive behavioural group therapy for patients diagnosed with mild cognitive impairment and their significant others: feasibility and preliminary results.
    Joosten-Weyn Banningh LW; Kessels RP; Olde Rikkert MG; Geleijns-Lanting CE; Kraaimaat FW
    Clin Rehabil; 2008 Aug; 22(8):731-40. PubMed ID: 18678573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stress-induced blood pressure elevation in subjects with mild cognitive impairment: effects of the dual-type calcium channel blocker, cilnidipine.
    Kawashima Y; Akishita M; Hasegawa H; Kozaki K; Toba K
    Geriatr Gerontol Int; 2008 Dec; 8(4):278-83. PubMed ID: 19149840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
    Olsson EM; von Schéele B; Panossian AG
    Planta Med; 2009 Feb; 75(2):105-12. PubMed ID: 19016404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial.
    Altman RD; Dreiser RL; Fisher CL; Chase WF; Dreher DS; Zacher J
    J Rheumatol; 2009 Sep; 36(9):1991-9. PubMed ID: 19648310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
    Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soya isoflavone supplementation enhances spatial working memory in men.
    Thorp AA; Sinn N; Buckley JD; Coates AM; Howe PR
    Br J Nutr; 2009 Nov; 102(9):1348-54. PubMed ID: 19480732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginkgo biloba: specificity of neuropsychological improvement--a selective review in search of differential effects.
    Kaschel R
    Hum Psychopharmacol; 2009 Jul; 24(5):345-70. PubMed ID: 19551805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial.
    Rème CA; Dramard V; Kern L; Hofmans J; Halsberghe C; Mombiela DV
    Vet Ther; 2008; 9(2):69-82. PubMed ID: 18597245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.